An EAACI “European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI)”: the methodology-Reference-Cited by-同舟云学术

An EAACI “European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI)”: the methodology

Published:2014-01 Issue:1 Volume:4 Page:22
ISSN:2045-7022
Container-title:Clinical and Translational Allergy
language:en
Short-container-title:Clinical and Translational Allergy

Author:

Calderón Moises A¹,Rodríguez del Río Pablo²,Vidal Carmen³,Just Jocelyne⁴,Pfaar Oliver⁵,Linneberg Allan⁶⁷⁸,Demoly Pascal⁹

Affiliation:

1. Section of Allergy and Clinical ImmunologyImperial College LondonNational Heart and Lung InstituteRoyal Brompton HospitalLondonUK

2. Allergy SectionHospital Infantil Universitario Niño JesúsMadridSpain

3. Allergy DepartmentComplejo Hospitalario Universitario de SantiagoSantiago de CompostelaSpain

4. Allergology DepartmentCentre de l'Asthme et des Allergies. Hôpital d'Enfants Armand‐Trousseau (APHP)‐Sorbonne Universités, UPMC Univ Paris 06UMR_S 1136Institut Pierre Louis d'Epidémiologie et de Santé PubliqueEquipe EPARF‐75013 75571ParisCedex 12France

5. Center for Rhinology and AllergologyDepartment of OtorhinolaryngologyHead and Neck SurgeryUniversity Hospital MannheimWiesbadenGermany

6. Research Centre for Prevention and Healththe Capital Region of DenmarkGlostrupDenmark

7. Department of Clinical Experimental ResearchGlostrup University HospitalGlostrupDenmark

8. Department of Clinical MedicineFaculty of Health and Medical SciencesUniversity of CopenhagenCopenhagenDenmark

9. Département de Pneumologie et AddictologieHôpital Arnaud de VilleneuveUniversity Hospital of Montpellier, Sorbonne Universités, UPMC Paris 06, UMR‐S 1136, IPLESPEquipe EPAR75013ParisFrance

Publisher

Wiley

Subject

Immunology and Allergy,Immunology,Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1186/2045-7022-4-22

Reference28 articles.

1. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper;Bousquet J;J Allergy Clin Immunol,1998

2. Long‐term clinical efficacy of grass‐pollen immunotherapy;Durham SR;N Engl J Med,1999

3. Allergen‐specific immunotherapy for respiratory allergies: from meta‐analysis to registration and beyond;Calderón MA;J Allergy Clin Immunol,2011

4. Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report;Burks AW;J Allergy Clin Immunol,2013

5. Increased frequency of large local reactions among systemic reactors during subcutaneous allergen immunotherapy;Roy SR;Ann Allergy Asthma Immunol,2007

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allergen immunotherapy adverse events in adults with respiratory allergies‐data from ADER: An EAACI task force report;Allergy;2024-08-22

2. In Silico Design of a New Epitope-Based Vaccine against Grass Group 1 Allergens;Advances in Respiratory Medicine;2023-11-08

3. The Allergen Immunotherapy Adverse Events Registry: Setup & methodology of a European Academy of Allergy and Clinical Immunology taskforce project;Clinical and Translational Allergy;2023-06

4. Adverse events in children and adolescents undergoing allergen immunotherapy for respiratory allergies—Report from the Allergen Immunotherapy Adverse Events Registry (ADER), a European Academy of Allergy and Clinical Immunology taskforce;Clinical and Translational Allergy;2023-06

5. Real-life studies in allergen immunotherapy;Current Opinion in Allergy & Clinical Immunology;2021-06-14